Connect
MJA
MJA

Acute kidney injury in an older patient

Luke Vlismas, Hannah Coleman, Tom N Lea-Henry and Bobby Chacko
Med J Aust 2018; 209 (10): . || doi: 10.5694/mja18.00045
Published online: 19 November 2018

Clinical record


  • 1 John Hunter Hospital, Newcastle, NSW
  • 2 University of Newcastle, Newcastle, NSW



Competing interests:

No relevant disclosures.

  • 1. Therapeutic Goods Administration. Piperacillin sodium – medicine shortage information. http://apps.tga.gov.au/Prod/msi/Search/Details/piperacillin-sodium (viewed Sept 2018).
  • 2. Rutter WC, Cox JN, Martin CA, et al. Nephrotoxicity during vancomycin therapy in combination with piperacillin–tazobactam or cefepime. Antimicrob Agents Chemother 2017; 61: 1-9.
  • 3. Muriithi AK, Leung N, Valeri AM, et al. Biopsy-proven acute interstitial nephritis, 1993–2011: a case series. Am J Kidney Dis 2014; 64: 558-566.
  • 4. Praga M, Gonzalez E. Acute interstitial nephritis. Kidney Int 2010; 77: 956-961.
  • 5. Raghavan R, Eknoyan G. Acute interstitial nephritis – a reappraisal and update. Clin Nephrol 2014; 82: 149-162.
  • 6. Mac K, Chavada R, Paull S, Howlin K, Wong J. Cefepime induced acute interstitial nephritis – a case report. BMC Nephrol 2015; 16: 15.
  • 7. Alzubaidi M SS, Velez JC. Acute interstitial nephritis with cast formation associated with exposure to cefepime [abstract]. Am J Kidney Dis 2016; 67: A1-A118.
  • 8. Perazella MA. Diagnosing drug-induced AIN in the hospitalized patient: a challenge for the clinician. Clin Nephrol 2014; 81: 381-388.

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.